EP 3634405 A4 20210609 - METHODS FOR DETECTING DYSBIOSIS AND TREATING SUBJECTS WITH DYSBIOSIS
Title (en)
METHODS FOR DETECTING DYSBIOSIS AND TREATING SUBJECTS WITH DYSBIOSIS
Title (de)
VERFAHREN ZUM NACHWEIS VON DYSBIOSE UND ZUR BEHANDLUNG VON PATIENTEN MIT DYSBIOSE
Title (fr)
PROCÉDÉS DE DÉTECTION DE DYSBIOSE ET DE TRAITEMENT DE SUJETS ATTEINTS D'UNE DYSBIOSE
Publication
Application
Priority
- US 201762505637 P 20170512
- US 2018032436 W 20180511
Abstract (en)
[origin: WO2018209307A1] Provided herein are, inter alia, methods, compositions, and systems, for detecting and treating lung dysbiosis. In aspects, included herein are methods, compositions, and systems for detecting infections (such as Aspergillus sp. infections and Mycobacterium sp. infections), or the risk thereof, as well as for treating such infections. Also provided are methods, compositions, and systems for detecting whether a subject who has pneumonia and is infected with HIV has an increased risk of dying compared to a general population of subjects who have pneumonia and are infected with HIV. Methods, compositions, and systems for monitoring subjects diagnosted as having a disease or risk as disclosed herein are also included.
IPC 8 full level
A61K 31/4196 (2006.01); A61K 31/47 (2006.01); A61K 31/575 (2006.01); A61P 11/00 (2006.01); A61P 31/04 (2006.01); A61P 31/06 (2006.01); A61P 31/10 (2006.01); A61P 31/18 (2006.01); C12Q 1/04 (2006.01); C12Q 1/6883 (2018.01); C12Q 1/689 (2018.01); G01N 33/68 (2006.01); G01N 33/88 (2006.01); G01N 33/92 (2006.01)
CPC (source: EP US)
A61K 31/4196 (2013.01 - EP); A61K 31/4409 (2013.01 - US); A61K 31/47 (2013.01 - EP); A61K 31/496 (2013.01 - US); A61K 31/575 (2013.01 - EP); A61P 11/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/06 (2017.12 - EP US); A61P 31/10 (2017.12 - EP US); A61P 31/18 (2017.12 - EP); C12Q 1/04 (2013.01 - EP US); C12Q 1/6883 (2013.01 - EP); C12Q 1/689 (2013.01 - EP US); C12Q 1/6895 (2013.01 - US); G01N 33/88 (2013.01 - EP US); G01N 33/92 (2013.01 - EP US); G01N 2333/16 (2013.01 - EP US); G01N 2800/12 (2013.01 - EP US)
Citation (search report)
- [X] EP 3146974 A1 20170329 - UNIV CLAUDE BERNARD - LYON 1 [FR], et al
- [XY] ZELIN CUI ET AL: "Complex sputum microbial composition in patients with pulmonary tuberculosis", BMC MICROBIOLOGY, BIOMED CENTRAL LTD, GB, vol. 12, no. 1, 23 November 2012 (2012-11-23), pages 276, XP021134885, ISSN: 1471-2180, DOI: 10.1186/1471-2180-12-276
- [XY] SEGAL LEOPOLDO N ET AL: "Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients", CELL HOST & MICROBE, ELSEVIER, NL, vol. 21, no. 4, 30 March 2017 (2017-03-30), pages 530, XP029977713, ISSN: 1931-3128, DOI: 10.1016/J.CHOM.2017.03.003
- See references of WO 2018209307A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018209307 A1 20181115; EP 3634405 A1 20200415; EP 3634405 A4 20210609; US 2020197389 A1 20200625
DOCDB simple family (application)
US 2018032436 W 20180511; EP 18797645 A 20180511; US 201816609118 A 20180511